Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | UTHR |
---|---|---|
09:32 ET | 5914 | 236.075 |
09:34 ET | 100 | 235.92 |
09:36 ET | 260 | 234.9492 |
09:38 ET | 443 | 235.495 |
09:41 ET | 957 | 235.565 |
09:43 ET | 300 | 236.03 |
09:50 ET | 200 | 237.37 |
09:52 ET | 300 | 237.38 |
09:54 ET | 1075 | 237.715 |
09:56 ET | 1048 | 236.53 |
09:59 ET | 100 | 236.61 |
10:01 ET | 100 | 236.115 |
10:03 ET | 213 | 236.44 |
10:06 ET | 322 | 236.46 |
10:08 ET | 350 | 236.35 |
10:10 ET | 100 | 236.375 |
10:14 ET | 1717 | 236.26 |
10:17 ET | 100 | 236.085 |
10:19 ET | 700 | 236.47 |
10:24 ET | 400 | 236.2475 |
10:26 ET | 2201 | 236.14 |
10:28 ET | 200 | 235.86 |
10:30 ET | 200 | 235.815 |
10:32 ET | 300 | 235.91 |
10:33 ET | 400 | 235.88 |
10:35 ET | 1100 | 236 |
10:39 ET | 2000 | 235.815 |
10:42 ET | 500 | 235.785 |
10:44 ET | 100 | 235.97 |
10:48 ET | 400 | 236.01 |
10:50 ET | 200 | 235.82 |
10:51 ET | 1115 | 236.19 |
10:53 ET | 500 | 236.27 |
10:55 ET | 2600 | 236.12 |
10:57 ET | 1025 | 236.02 |
11:00 ET | 900 | 235.81 |
11:02 ET | 1462 | 235.57 |
11:08 ET | 1015 | 235.44 |
11:09 ET | 429 | 235.4 |
11:11 ET | 100 | 235.4 |
11:13 ET | 500 | 235.305 |
11:15 ET | 200 | 235.37 |
11:18 ET | 1118 | 235.505 |
11:20 ET | 300 | 235.41 |
11:22 ET | 300 | 235.47 |
11:24 ET | 1000 | 235.49 |
11:26 ET | 901 | 235.69 |
11:27 ET | 800 | 235.96 |
11:29 ET | 100 | 235.73 |
11:31 ET | 1197 | 235.52 |
11:33 ET | 341 | 235.43 |
11:36 ET | 300 | 235.465 |
11:38 ET | 100 | 235.455 |
11:40 ET | 300 | 235.425 |
11:42 ET | 253 | 235.42 |
11:44 ET | 200 | 235.405 |
11:45 ET | 1074 | 235.57 |
11:47 ET | 101 | 235.525 |
11:49 ET | 500 | 235.47 |
11:51 ET | 254 | 235.505 |
11:54 ET | 200 | 235.535 |
11:56 ET | 191 | 235.485 |
11:58 ET | 300 | 235.55 |
12:00 ET | 356 | 235.68 |
12:02 ET | 200 | 235.635 |
12:03 ET | 311 | 235.89 |
12:05 ET | 1600 | 235.935 |
12:07 ET | 900 | 236.095 |
12:12 ET | 2394 | 235.89 |
12:14 ET | 401 | 236.04 |
12:16 ET | 200 | 235.865 |
12:18 ET | 461 | 235.95 |
12:20 ET | 3379 | 234.99 |
12:21 ET | 972 | 235.29 |
12:23 ET | 800 | 235.395 |
12:25 ET | 200 | 235.365 |
12:27 ET | 1100 | 235.49 |
12:30 ET | 1006 | 235.59 |
12:32 ET | 1125 | 235.675 |
12:34 ET | 1000 | 235.64 |
12:36 ET | 717 | 235.81 |
12:38 ET | 425 | 235.63 |
12:39 ET | 300 | 235.685 |
12:41 ET | 2400 | 235.685 |
12:43 ET | 3792 | 235.675 |
12:45 ET | 2576 | 234.92 |
12:48 ET | 300 | 234.685 |
12:50 ET | 3939 | 234.6 |
12:52 ET | 800 | 234.69 |
12:54 ET | 500 | 234.4 |
12:56 ET | 500 | 234.35 |
12:57 ET | 100 | 234.52 |
12:59 ET | 400 | 234.455 |
01:01 ET | 1000 | 234.3 |
01:03 ET | 471 | 234.48 |
01:06 ET | 400 | 234.39 |
01:08 ET | 395 | 234.38 |
01:10 ET | 1061 | 234.43 |
01:14 ET | 700 | 234.625 |
01:15 ET | 986 | 234.62 |
01:17 ET | 803 | 234.65 |
01:19 ET | 400 | 234.69 |
01:21 ET | 202 | 234.79 |
01:24 ET | 1707 | 234.5 |
01:26 ET | 650 | 234.5 |
01:28 ET | 631 | 234.43 |
01:30 ET | 200 | 234.46 |
01:32 ET | 917 | 234.615 |
01:33 ET | 300 | 234.65 |
01:35 ET | 300 | 234.645 |
01:37 ET | 1900 | 234.6 |
01:39 ET | 1311 | 234.945 |
01:42 ET | 1100 | 234.9 |
01:44 ET | 100 | 234.9 |
01:46 ET | 700 | 235.1 |
01:50 ET | 600 | 235.36 |
01:51 ET | 200 | 235.235 |
01:53 ET | 600 | 235.39 |
01:55 ET | 1300 | 235.37 |
01:57 ET | 899 | 235.615 |
02:00 ET | 1300 | 235.72 |
02:02 ET | 200 | 235.87 |
02:04 ET | 812 | 235.72 |
02:06 ET | 6029 | 235.26 |
02:08 ET | 1100 | 235.29 |
02:09 ET | 2380 | 235.29 |
02:11 ET | 300 | 235.29 |
02:13 ET | 6748 | 235.225 |
02:15 ET | 700 | 235.34 |
02:18 ET | 1525 | 235.745 |
02:20 ET | 200 | 235.55 |
02:26 ET | 673 | 235.89 |
02:29 ET | 3014 | 235.67 |
02:33 ET | 1964 | 235.81 |
02:36 ET | 225 | 235.73 |
02:38 ET | 1235 | 235.935 |
02:40 ET | 100 | 235.795 |
02:42 ET | 1725 | 235.85 |
02:44 ET | 100 | 235.755 |
02:45 ET | 2601 | 235.75 |
02:47 ET | 1000 | 235.74 |
02:49 ET | 10067 | 235.53 |
02:51 ET | 800 | 235.47 |
02:54 ET | 700 | 235.595 |
02:56 ET | 800 | 235.58 |
02:58 ET | 1500 | 235.73 |
03:00 ET | 2855 | 235.6 |
03:02 ET | 600 | 235.665 |
03:03 ET | 500 | 235.75 |
03:05 ET | 100 | 235.67 |
03:07 ET | 700 | 235.615 |
03:09 ET | 300 | 235.61 |
03:12 ET | 4184 | 234.975 |
03:14 ET | 300 | 235 |
03:16 ET | 1443 | 235.155 |
03:18 ET | 200 | 235.1 |
03:20 ET | 200 | 235 |
03:21 ET | 1555 | 234.76 |
03:23 ET | 200 | 234.805 |
03:25 ET | 1423 | 235.11 |
03:27 ET | 1959 | 235.39 |
03:30 ET | 1000 | 235.44 |
03:32 ET | 1922 | 235.405 |
03:34 ET | 1825 | 235.52 |
03:36 ET | 1600 | 235.45 |
03:38 ET | 4811 | 235.265 |
03:39 ET | 2893 | 235.33 |
03:41 ET | 425 | 235.295 |
03:43 ET | 2669 | 235.35 |
03:45 ET | 3799 | 235.625 |
03:48 ET | 4400 | 235.865 |
03:50 ET | 8213 | 235.65 |
03:52 ET | 3592 | 235.12 |
03:54 ET | 4317 | 235.1643 |
03:56 ET | 16044 | 234.7 |
03:57 ET | 9089 | 234.67 |
03:59 ET | 15829 | 234.33 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
United Therapeutics Corp | 10.4B | 11.8x | +8.22% |
Exact Sciences Corp | 10.9B | -52.3x | --- |
Qiagen NV | 9.4B | 27.7x | +12.66% |
Medpace Holdings Inc | 12.0B | 39.6x | +35.10% |
Biomarin Pharmaceutical Inc | 15.3B | 76.4x | --- |
Neurocrine Biosciences Inc | 13.8B | 56.6x | +62.04% |
United Therapeutics Corporation is a pharmaceutical company. It markets and sells commercial therapies to treat pulmonary arterial hypertension (PAH): Tyvaso DPI (treprostinil) Inhalation Powder (Tyvaso DPI); Tyvaso (treprostinil) Inhalation Solution (nebulized Tyvaso), which includes the Tyvaso Inhalation System; Remodulin (treprostinil) Injection (Remodulin); Orenitram (treprostinil) Extended-Release Tablets (Orenitram); and Adcirca (tadalafil) Tablets (Adcirca). Tyvaso DPI and nebulized Tyvaso are also approved to treat pulmonary hypertension associated with interstitial lung disease (PH-ILD). It also markets and sells an oncology product, Unituxin (dinutuximab) Injection (Unituxin) for treatment of high-risk neuroblastoma, and the Remunity Pump for Remodulin (Remunity). Tyvaso DPI is a drug-device combination product that incorporates the dry powder formulation technology and Dreamboat inhalation device technology used in MannKind’s Afrezza (insulin human) Inhalation Powder.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $10.4B |
---|---|
Revenue (TTM) | $2.3B |
Shares Outstanding | 44.3M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.54 |
EPS | $19.82 |
Book Value | $127.23 |
P/E Ratio | 11.8x |
Price/Sales (TTM) | 4.5 |
Price/Cash Flow (TTM) | 10.0x |
Operating Margin | 50.91% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.